Literature DB >> 16219683

Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling.

Charles E Chalfant1, Sarah Spiegel.   

Abstract

The phosphorylated sphingolipid metabolites sphingosine 1-phosphate (S1P) and ceramide 1-phosphate (C1P) have emerged as potent bioactive agents. Recent studies have begun to define new biological functions for these lipids. Generated by sphingosine kinases and ceramide kinase, they control numerous aspects of cell physiology, including cell survival and mammalian inflammatory responses. Interestingly, S1P is involved in cyclooxygenase-2 induction and C1P is required for the activation and translocation of cPLA2. This suggests that these two sphingolipid metabolites may act in concert to regulate production of eicosanoids, important inflammatory mediators. Whereas S1P functions mainly via G-protein-coupled receptors, C1P appears to bind directly to targets such as cPLA2 and protein phosphatase 1/2A. S1P probably also has intracellular targets, and in plants it appears to directly regulate the G protein alpha subunit GPA1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16219683     DOI: 10.1242/jcs.02637

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  146 in total

1.  Neutral sphingomyelinase activation precedes NADPH oxidase-dependent damage in neurons exposed to the proinflammatory cytokine tumor necrosis factor-α.

Authors:  Brian M Barth; Sally J Gustafson; Thomas B Kuhn
Journal:  J Neurosci Res       Date:  2011-09-19       Impact factor: 4.164

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

3.  Sphingosine 1-phosphate-metabolizing enzymes control influenza virus propagation and viral cytopathogenicity.

Authors:  Young-Jin Seo; Celeste Blake; Stephen Alexander; Bumsuk Hahm
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

4.  Genetic sphingosine kinase 1 deficiency significantly decreases synovial inflammation and joint erosions in murine TNF-alpha-induced arthritis.

Authors:  DeAnna A Baker; Jeremy Barth; Raymond Chang; Lina M Obeid; Gary S Gilkeson
Journal:  J Immunol       Date:  2010-07-19       Impact factor: 5.422

Review 5.  G Protein-coupled Receptor Biased Agonism.

Authors:  Sima Y Hodavance; Clarice Gareri; Rachel D Torok; Howard A Rockman
Journal:  J Cardiovasc Pharmacol       Date:  2016-03       Impact factor: 3.105

6.  Role of sphingosine 1-phosphate in human pancreatic cancer cells proliferation and migration.

Authors:  Yun-Xia Guo; Ying-Jie Ma; Li Han; Yu-Jie Wang; Ji-Ao Han; Ying Zhu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells.

Authors:  Sonja Balthasar; Johanna Samulin; Hanna Ahlgren; Nina Bergelin; Mathias Lundqvist; Emil C Toescu; Margaret C Eggo; Kid Törnquist
Journal:  Biochem J       Date:  2006-09-15       Impact factor: 3.857

Review 8.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis.

Authors:  Volker Brinkmann; Andreas Billich; Thomas Baumruker; Peter Heining; Robert Schmouder; Gordon Francis; Shreeram Aradhye; Pascale Burtin
Journal:  Nat Rev Drug Discov       Date:  2010-10-29       Impact factor: 84.694

Review 9.  Sphingosine phosphate lyase insufficiency syndrome (SPLIS): A novel inborn error of sphingolipid metabolism.

Authors:  Youn-Jeong Choi; Julie D Saba
Journal:  Adv Biol Regul       Date:  2018-09-25

10.  Caged ceramide 1-phosphate analogues: synthesis and properties.

Authors:  Ravi S Lankalapalli; Alberto Ouro; Lide Arana; Antonio Gómez-Muñoz; Robert Bittman
Journal:  J Org Chem       Date:  2009-11-20       Impact factor: 4.354

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.